INNA VIKTOROVNA DRUK
@omsk-osma.ru
Scopus Publications
- Metabolic and cardioprotective effects of ipragliflozin in patients with type 2 diabetes mellitus and arterial hypertension
I.V. Druk, S.S. Safronova, O.I. Kanunnikova, U.A. Bykova, T.A. Ushakova, et al.
Russian Medical Inquiry, 2025
Aim: to study an effect of ipragliflozin (i. e., a type 2 sodiumglucose cotransporter inhibitor ( SGLT2)) on metabolic parameters, as well as on structural and functional cardiac characteristics in patients with type 2 diabetes mellitus (DM2) and arterial hypertension (AH) without atherosclerotic cardiovascular diseases (ACVD). Materials and Methods: a prospective cohort study included 30 patients with DM2, AH and left ventricular diastolic dysfunction (LVDD) (14 males, age — 54.0 [50.0; 60.0] years) receiving ipragliflozin (50 mg once a day) in addition to the current hypoglycemic therapy. General clinical, laboratory and instrumental tests (including electrocardiography, Holter monitoring, and a 6minute walking test), as well as physical performance, quality of life, adherence to the therapy and drug tolerance were assessed. Results: in 12 weeks of the followup, 14 patients did not meet the LVDD criteria, and 18 patients did not meet them in 24 weeks. On Week 24 of the ipragliflozin therapy, general positive trends were reported in subjective status and 6minute walk test results. Body weight, BMI, waist circumference, ABSI, body roundness index, fasting glucose, as well as HbA1c, ALT, and NTproBNP levels decreased significantly (p<0.001). Also, ipragliflozin significantly (p<0.001) affected shortterm blood pressure variability (a decrease in mean systolic and diastolic blood pressure at day and night), and a significant decrease in a number of episodes of supraventricular and ventricular extrasystoles is demonstrated. Several signs that can be considered as markers of a lower probability of response to SGLT2 (ipragliflozin) therapy resulting in elimination of LVDD signs in 12 and 24 weeks, have been identified. After the therapy, a total index according to the Minnesota Living with Heart Failure Questionnaire decreased significantly (p<0.001). When analyzing adherence to the therapy with the KOP25 questionnaire, a positive trend was reported for Importance of Lifestyle Modification (p<0.001). Conclusion: clinically significant metabolic and cardioprotective effects of ipragliflozin (i.e., a SGLT2) were demonstrated for the first time in pa - tients with DM2, AH and LVDD without ACVD in a shortterm followup. This may justify the advantages of its application in this group of patients. KEYWORDS: diabetes mellitus type 2, arterial hypertension, diastolic dysfunction, therapy, ipragliflozin. FOR CITATION: Druk I.V., Safronova S.S., Kanunnikova O.I., Bykova U.A., Ushakova T.A., Novitskaya M.V. Metabolic and cardioprotective effects of ipragliflozin in patients with type 2 diabetes mellitus and arterial hypertension. Russian Medical Inquiry. 2025;9(10):710–719 (in Russ.). DOI: 10.32364/2587-6821-2025-9-10-3 - Polycystic ovary syndrome and cardiovascular disease risk
E. A. Savchuk, I. V. Druk, M. N. Mamedov
Rational Pharmacotherapy in Cardiology, 2025
Aim . To define and discuss the main pathogenic mechanisms of polycystic ovary syndrome (PCOS) and its association with cardiometabolic risk factors. Material and methods . The material for this nonsystematic review was collected from peer-reviewed articles published in PubMed, eLibrary.RU, CyberLeninka, and other research databases from 2006 to 2024 using the following terms: polycystic ovary syndrome, cardiometabolic risk factors, phenotypes, and cardiovascular diseases. Results . Population studies suggest that the risk of hypertension and cardiovascular diseases is higher in the reproductive age group compared to the general population. An increased risk of cardiovascular diseases in younger individuals (children, adolescents) may be associated with maternal PCOS. The transition to menopause is likely not associated with a deterioration in the cardiometabolic profile, which may be linked to improvements in the phenotypic features of PCOS with age. Cardiometabolic risk varies depending on the PCOS phenotype, which may support a new classification approach to PCOS. Mendelian randomization studies indicate that it is not PCOS itself, but rather the associated factors (obesity, hyperandrogenism), that likely explain the epidemiological link between PCOS and cardiometabolic diseases. According to published international guidelines for the treatment of PCOS, women with PCOS should regularly assess their overall cardiovascular risk in order to individualize therapy. Conclusion . Women with PCOS are at increased risk for cardiovascular diseases and cardiometabolic disorders compared to the general population. However, the degree of risk may depend on the PCOS phenotype and the stage of life. Further research is needed, including studies in different age groups (adolescents, reproductive age, menopause, postmenopause), to determine the most effective strategies for reducing the cardiovascular disease risk associated with PCOS. - Features of extracellular trap formation in response to neutrophil leukocyte stimulation by thrombin in patients with diabetes mellitus and various types of diabetic foot damage
Inna Viktorovna Druk, Dmitry Georgyevich Novikov, Alexander Nikolaevich Zolotov, Nikolay Aleksandrovich Kirichenko, Elizaveta Alexandrovna Kirch, et al.
Medical News of North Caucasus, 2025 - Identification of low-density neutrophils and features of forming neutrophil extracellular traps in patients with diabetic osteoarthropathy (Charcot foot)
Inna V. Druk, Dmitry G. Novikov, Alexander N. Zolotov, Nikolay А. Kirichenko, Elizaveta A. Kirkh, et al.
Vestnik Sovremennoi Klinicheskoi Mediciny, 2025
Introduction. Charcot neuroarthropathy is a severe complication of diabetes mellitus. Although the clinical picture of Charcot neuroarthropathy is well-defined, the underlying immunological mechanisms have not been fully elucidated, thereby constraining the efficacy of therapeutic approaches, particularly those aimed at osteoclast inhibition. An important research trend is the studies of abnormal neutrophil activation and their ability to form extracellular traps. Aim. To study the features of forming neutrophil extracellular traps by leukocytes isolated from venous blood in patients with type 1 and type 2 diabetes mellitus complicated by diabetic foot syndrome without and Charcot neuroarthropathy. Materials and Methods. Three groups were examined: “Control” (healthy volunteers, n=12), “Patients with diabetic foot syndrome” (n=7), “Charcot foot” (n=8). Cells were isolated by gradient centrifugation on Ficoll-Verografin. Cell samples from the mononuclear and granulocyte fractions were examined using light microscopy (Romanowsky-Giemsa stain) and luminescence microscopy (neutrophil extracellular traps were stained with propidium iodide). Spontaneous and induced NETosis was assessed ex vivo. Results and Discussion. In the mononuclear fraction without stimulation, cloud-shaped and filamentous extracellular traps that had been absent in the “Control” group, were detected in both groups of patients, indicating spontaneous NETosis. Number of cloud-shaped neutrophil extracellular traps was higher in the “Charcot foot” group (p=0.0175), while filamentous traps were significantly more frequent in both patient groups compared to the control (p=0.0379 and p=0.0006, respectively), with a predominance of filamentous forms in the “Charcot foot” group. In the granulocyte fraction, an increase in filamentous traps was noted in the “Patients with diabetic foot syndrome” group (p=0.0141). The “Charcot foot” group showed pronounced interindividual variability. Induced NETosis in the “Charcot foot” group in the granulocyte fraction was characterized by a predominance of filamentous neutrophil extracellular traps (p=0.0093). After exposure to an antigenic stimulator (probiotic), both patient groups showed a low ability of normal-density neutrophils to form extracellular traps, indicating a weakening of their antimicrobial activity implemented via this mechanism. Conclusions. Neutrophils of normal and low density were identified in the blood of patients with diabetes mellitus. In patients with diabetic foot syndrome and Charcot neuroarthropathy, low-density neutrophils and, possibly, monocytes are prone to spontaneously forming extracellular traps, which is more pronounced in the “Charcot foot” group. Induced NETosis was characterized by predominantly forming filamentous extracellular traps and especially intense in the “Charcot foot” group. Normal-density neutrophils in the patient groups are characterized by a reduced ability for induced NETosis in response to antigenic stimulation with a probiotic. - Investigation of neutrophil extracellular traps in patients with type 2 diabetes mellitus, diabetic peripheral neuropathy and diabetic foot syndrome
Clinical Review for General Practice, 2025 - Academic schools of internal and preventive medicine: vectors for the development of physician/professionalism
O. M. Drapkina, S. Yu. Astanina, R. N. Shepel, D. R. Akberova, R. K. Ashurbayeva, et al.
Cardiovascular Therapy and Prevention Russian Federation, 2025
This article defines the role of academic schools of internal and preventive medicine in the unified educational environment for training physicians in the field of internal medicine. The 5 th International Research and Practice Forum "Academic Schools of Internal and Preventive Medicine" is analyzed in relation to the development of a unified educational environment for training general practitioners and internists. Within the unified educational environment for training general practitioners and internists, academic schools of internal and preventive medicine act as a system-forming factor, ensuring the implementation of the Forum's guiding idea: "A Unified Educational Environment Is a Vector for the Development of Specialist Professionalism". - Comorbid patient with obesity: comparative assessment of the effect of intermittent or continuous calorie restriction on body weight and cardiometabolic risk markers
Z. M. Nagoeva, I. V. Druk, K. A. Martirosian
Experimental and Clinical Gastroenterology, 2024
The purpose of this study is to present the results of a comparative assessment of the effect of intermittent restricted diet (ICR) with a constant restricted diet (CCR) on weight loss, fat mass, the effect on cardiometabolic risk markers, glucose and insulin levels in obese adults. Materials and methods: The works cited in the study were selected using the keywords “obesity”, “comorbidity”, “weight loss”, “intermittent calorie restriction”, “constant calorie restriction”, in the search engines PubMed, Scopus. Publications had to meet the following criteria: randomized clinical trials, published in the last decade (2014-2024), access to the full text of the publication, the primary endpoint of weight loss, intermittent or continuous calorie restriction as the main intervention, adult population, subjects with obesity and comorbid pathology. Results: Obesity has acquired pandemic proportions worldwide. In some countries, prevalence rates range from 20 to 40%. Prevalence and incidence rates continue to increase. It is estimated that by 2030, almost 50% of the world’s population will be overweight or obese. Obesity increases the risk of a number of chronic noncommunicable diseases (T2DM, CVD, CKD, CLD, some types of cancer). Weight loss is the main intervention for people with overweight and obesity. Conservative non-drug therapy in the form of nutritional modification is the mainstay of obesity treatment and is recommended as the first, mandatory and permanent component of treatment. Daily caloric restriction and intermittent feeding are two forms of dietary therapy that can help to reduce body weight. Conclusion: Based on the results of the comparative analysis, we concluded that ICR and CCR are alternative energy restriction regimens for weight loss with comparable improvements in obesity-related cardiometabolic risk markers. Both regimens were well tolerated in most studies and may be equivalent approaches to weight loss. Further studies are needed to examine the efficacy, feasibility and safety of ICR in patients with chronic diseases such as type 2 diabetes, cardiovascular disease or cancer. - Not iodine alone. Role of selenium, zinc, vitamins A, C, E in the physiology and pathology of the thyroid gland
Dmitry I. Trukhan, Inna V. Druk, Inna A. Viktorova, and
Clinical Review for General Practice, 2024
Diseases of the thyroid gland occupy one of the central places in clinical endocrinology. The main components for the synthesis of thyroid hormones are iodine and the amino acid tyrosine. Studies conducted in the 21st century indicate a certain effect on the metabolism and function of the thyroid gland and other microelements and vitamins. We searched the PubMed and Scopus information databases for publications devoted to the study of the influence of trace elements selenium, zinc, vitamins A, C, E on the physiology and pathology of the thyroid gland, including sources up to 29.02.2024. Adequate intake of selenium, zinc, along with two other important microelements (iodine and iron), as well as vitamins A, C, E, contributes to normal metabolism of the thyroid gland. Maintaining a physiological balance of micronutrients and vitamins through a sensible diet or taking nutraceuticals is essential to preventing thyroid disease and maintaining overall health. Basal analysis of microelements and vitamins seems appropriate for better selection of patients in need of replacement therapy using nutraceuticals - Macrovascular and microvascular complications of type 2 diabetes mellitus
M.N. Mamedov, I.V. Druk, G.G. Arabidze, Kh.R. Akhundova
Profilakticheskaya Meditsina, 2024 - Continuum of type 2 diabetes mellitus and its comorbidity with other somatic diseases
M.N. Mamedov, I.V. Druk, G.G. Arabidze, Kh.R. Akhundova
Profilakticheskaya Meditsina, 2024 - The Department of Medical Sciences of the RAS, Therapeutic Sciences Council meeting: Scientific projects marathon of Russian therapeutic departments "From innovative technologies and education to healthcare practice. Connective tissue diseases: diagnostic and therapeutic challenges"
O. M. Drapkina, I. A. Viktorova, I. V. Druk, G. I. Nechaeva, E. N. Loginova, et al.
Cardiovascular Therapy and Prevention Russian Federation, 2024 - Methodological characteristics of the academic competition for general practitioners, family doctors and internists as a type of informal education
S. Yu. Astanina, S. A. Berns, S. R. Gilyarevsky, V. V. Gorban, I. V. Druk, et al.
Cardiovascular Therapy and Prevention Russian Federation, 2024 - Potential and limitations of secondary prevention of noncommunicable diseases: Data from a survey of Russian outpatient physicians
M. N. Mamedov, V. A. Kutsenko, О. M. Drapkina
Cardiovascular Therapy and Prevention Russian Federation, 2024 - Possibilities and limitations of secondary prevention of chronic non-communicable diseases in primary care of Russia and CIS countries
M.N. Mamedov, B.U. Mardanov, V.A. Kutsenko, O.M. Drapkina, L.A. Balykova, et al.
Profilakticheskaya Meditsina, 2024 - Priority of competencies in the professional activities of general practitioners (family doctors)
O. M. Drapkina, S. Yu. Astanina, R. N. Shepel, O. Yu. Kuznetsova, T. V. Samoilov, et al.
Cardiovascular Therapy and Prevention Russian Federation, 2024 - Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines
O. M. Drapkina, A. V. Kontsevaya, A. M. Kalinina, S. N. Avdeev, M. V. Agaltsov, et al.
Cardiovascular Therapy and Prevention Russian Federation, 2024 - International declaration of adherence to treatment 2023 («omsk declaration»): presentation for russian readers
Nikolai Nikolaev, Anatolii Martynov, Yulia Skirdenko, Kirill Andreevich Andreev, Alexander Vasilievich Gorbenko, et al.
Medical News of North Caucasus, 2024 - Glycemic control and cardiovascular complications of type 2 diabetes mellitus
I. V. Druk, S. S. Safronova
Meditsinskiy Sovet, 2023 - Videocapsular endoscopy in the diagnosis of gastrointestinal diseases
E. V. Usacheva, I. V. Druk, E. V. Nadey, N. A. Usachev
Experimental and Clinical Gastroenterology, 2023 - Hypertensive heart: from left ventricular hypertrophy to chronic heart failure
A. A. Semenkin, I. V. Druk, V. V. Potapov, V. S. Sapronenko, A. V. Zakharova
Arterial Hypertension Russian Federation, 2023 - Gastroesophageal reflux disease, obesity, bronchial asthma: simple combination or complex interaction
I. V. Druk, E. V. Usacheva, E. V. Nadey, S. S. Safronova, N. A. Usachev
Experimental and Clinical Gastroenterology, 2023 - General medical practice (family medicine) in the Omsk region as a part of the all-Russian tendencies: development, problems, perspectives
G.I. Nechaeva, I.V. Druk, I.A. Viktorova, M.A. Livzan, D.S. Ivanova
Profilakticheskaya Meditsina, 2023 - Comparative assessment of combined lipid-lowering therapy in patients with very high cardiovascular risk
I.V. Druk, O.Yu. Korennova, Yu.E. Yukhina, M.V. Savchenko, S.P. Podol'naya, et al.
Russian Medical Inquiry, 2023 - Omics technologies in the diagnosis of oncological diseases
E. N. Loginova, E. A. Kirch, E. A. Lyalyukova, I. V. Druk, G. I. Nechaeva, et al.
Eksperimental Naya I Klinicheskaya Gastroenterologiya Experimental and Clinical Gastroenterology, 2023 - Obesity: current state of the problem, multidisciplinary approach. (based on the consensus of the World Gastroenterological Organization “Obesity 2023” and the European guideline on obesity care in patients with gastrointestinal and liver diseases, 2022)
M. A. Livzan, E. A. Lyalyukova, I. V. Druk, S. S. Safronova, A. A. Khalashte, et al.
Experimental and Clinical Gastroenterology, 2023 - Efficacy of Follow-up Monitoring for Patients with Very High Cardiovascular Risk in the Omsk Region
Olga Yu. Korennova, Inna V. Druk, Svetlana P. Podolnaya, Marina V. Savchenko, Yulia E. Yuhina, et al.
Vestnik Vosstanovitel Noj Mediciny, 2022 - Pancreatic cancer, pancreatogenic diabetes, type 2 diabetes mellitus
I. V. Druk
Eksperimental Naya I Klinicheskaya Gastroenterologiya Experimental and Clinical Gastroenterology, 2022 - Metformin in the prevention of colorectal cancer with diabetes mellitus
I. V. Druk, E. A. Lyalyukova, E. A. Fadeeva
Eksperimental Naya I Klinicheskaya Gastroenterologiya Experimental and Clinical Gastroenterology, 2022 - Gallbladder cancer: epidemiology, risk factors
I. V. Druk, G. I. Nechaeva, E. A. Lyalyukova, E. V. Semenova
Eksperimental Naya I Klinicheskaya Gastroenterologiya Experimental and Clinical Gastroenterology, 2022 - Hyporesponse to statin therapy among patients with acute coronary syndrome: prevalence, impact on the development of heart failure in a short-term follow-up
I. V. Druk, O. Yu. Korennova, Yu. E. Yukhina, M. V. Savchenko, N. A. Maciyauskas, et al.
Russian Journal of Cardiology, 2022 - Risk factors of malignancy
I. V. Druk, E. V. Semenova, E. N. Loginova, O. Yu. Korennova, A. A. Semyonkin, et al.
Eksperimental Naya I Klinicheskaya Gastroenterologiya Experimental and Clinical Gastroenterology, 2022 - Role of genetic research in the prevention of life-threatening rhythm and cardiac conduction disorders in young people
E. N Loginova, E. A Kirh, G. I Nechaeva, A. I Martynov, I. V Druk, et al.
Russian Journal of Cardiology, 2022 - ECHOCARDIOGRAPHIC ANATOMICAL DISTINCTIVE CHARACTERISTICS OF THE LEFT VENTRICLE OF THE HEART IN MEN WITH CONNECTIVE TISSUE DYSPLASIA
Alexander Semenkin, Vladimir Sergeevich Sapronenko, Marina Shupina, Tereshchenko Yulia V., Zhivilova Lilia A., et al.
Medical News of North Caucasus, 2022 - Potential overtreatment of type 2 diabetes therapy in real clinical practice: Omsk oblast register data
I. V. Druk, D. I. Snarskaya, O. I. Goroshchenya
Diabetes Mellitus, 2021 - Left atrial myxoma and cardioembolic stroke in a young patient: a case report and literature review
О. Yu. Korennova, I. V. Druk, S. N. Starinskaya, J. V. Tereshchenko, Yu. T. Ignatiev, et al.
Arterial Hypertension Russian Federation, 2021 - Liver damage while Covid-19: Problems of pathogenesis and treatment
E. A. Lyalyukova, I. V. Dolgalev, E. N. Chernysheva, I. V. Druk, G. M. Konovalova, et al.
Eksperimental Naya I Klinicheskaya Gastroenterologiya Experimental and Clinical Gastroenterology, 2021 - Third phase of cardiac rehabilitation after acute coronary syndrome: prevalence of diabetes and its risk factors
Omsk State Medical University, Omsk, Russian Federation, I.V. Druk, O.Yu. Korennova, Omsk State Medical University, Omsk, Russian Federation, Clinical Cardiologic Dispensary, Omsk, Russian Federation, et al.
Russian Medical Inquiry, 2021 - Diet therapy in patients with metabolically associated fatty liver disease: what is the choice for particular patient?
E. A. Lyalyukova, I. V. Druk, I. V. Dolgalev, E. N. Chernysheva, E. N. Loginova, et al.
Eksperimental Naya I Klinicheskaya Gastroenterologiya Experimental and Clinical Gastroenterology, 2021 - Behavioral risk factors and clinical course of cardiovascular diseases and other noncommunicable diseases during quarantine in various regions of Russia
M. N. Mamedov, I. V. Druk, E. A. Turusheva, E. Yu. Eremina, T. E. Morozova, et al.
Russian Journal of Cardiology, 2021 - Assessment of coronary artery disease patient eligibility to phase 3 cardiac rehabilitation in the outpatient settings after myocardial revascularization
O. Yu. Korennova, E. P. Prihodko, Yu. E. Yukhina, M. V. Savchenko, E. A. Turusheva, et al.
Complex Issues of Cardiovascular Diseases, 2021 - Algorithms for adult outpatient care of coronavirus disease 2019 (COVID-19) and its assumption
M. A. Livzan, O. M. Drapkina, N. A. Nikolaev, Y. P. Skirdenko, R. N. Shepel, et al.
Cardiovascular Therapy and Prevention Russian Federation, 2021 - Yale food addiction scale (Version 2.0): Language and cultural adaptation
Inna Druk, Ashley Gearhardt, Galina Nechaeva
Medical News of North Caucasus, 2020 - Hypertension and cardiometabolic comorbidity in patients with different levels of blood glucose in the non-diabetic range
I. V. Druk, M. M. Ibragimova, D. V. Blazhko, L. A. Muratova, O. Yu. Korennova, et al.
Arterial Hypertension Russian Federation, 2020 - Dissection of the internal carotid artery in a patient with connective tissue dysplasia having risk variants of several candidate genes
I. V. Druk, O. V. Drokina, D. V. Smyalovsky, V. E. Smyalovsky, M. A. Shilova, et al.
Zhurnal Nevrologii I Psihiatrii Imeni S S Korsakova, 2019 - The role of meglumin sodium succinat infusions in reducing cardiovascular toxicity on cancer treatments
G. I. Nechaeva, E. A. Gaysina, I. V. Druk, E. N. Loginova, Yu. V. Tereshchenko, et al.
P A Herzen Journal of Oncology, 2019 - Efficacy and tolerability of a fixed combination of bisoprolol and perindopril in the treatment of hypertensive patients after revascularization for acute coronary syndrome
O. Yu. Korennova, E. A. Turusheva, S. P. Podolnaya, E. P. Prikhodko, Yu. E. Yukhina, et al.
Arterial Hypertension Russian Federation, 2019 - Pre-diabetes as an interdisciplinary problem: Definition, risks, approaches to the diagnostics and prevention of type 2 diabetes and cardiovascular complications
O. L. Barbarash, M. I. Voyevoda, G. R. Galstyan, M. V. Shestakova, S. A. Boytsov, et al.
Russian Journal of Cardiology, 2019 - Changes in the brain vascular bed associated with sudden death of young subjects
M. A. Shilova, I. V. Druk, I. V. Globa
Sudebno Meditsinskaya Ekspertiza, 2018 - Cerebral vascular syndrome of connective tissue dysplasia as a cause of subarachnoid hemorrhage in young patients
I. V. Druk, A. S. Rozhdestvensky, D. V. Smyalovsky, V. E. Smyalovsky, L. G. Galtsova, et al.
Zhurnal Nevrologii I Psihiatrii Imeni S S Korsakova, 2018 - Antihypertensive efficacy of fixed combination of amlodipine and ramipril in patients with arterial hypertension and very high cardiovascular risk
O. Yu. Korennova, S. P. Podolnaya, E. P. Prihodko, E. A. Turusheva, S. N. Starinskaya, et al.
Rational Pharmacotherapy in Cardiology, 2018 - Pathology of thoracic aorta in connective tissue dysplasias
G. I. Nechaeva, E. V. Semenova, A. A. Semenkin, I. V. Druk, V. P. Konev, et al.
Russian Journal of Cardiology, 2018 - Fixed combinations of perindopril and indapamide in hypertensive high-risk patients: Antihypertensive efficacy
O. Yu. Korennova, I. V. Druk, E. A. Turusheva, E. P. Prihodko, S. P. Podolnaya, et al.
Arterial Hypertension Russian Federation, 2017 - Modern approaches to the management of pregnancy and delivery in patients with marfan syndrome
Galina Nechaeva, Inna Druk, Ekaterina Loginova, Tatyana Smolnova, Marina Shupina, et al.
Medical News of North Caucasus, 2016 - Personalized Risk Assessment of Adverse Cardiovascular Events in Young Patients With Connective Tissue Dysplasia
I.V. Druk Druk, G.I. Nechaeva Nechaeva, O.V. Oseeva Oseeva, E.G. Pomorgajlo Pomorgajlo, V.N. Maksimov Maksimov, et al.
Kardiologiia, 2015 - Clinical experience of application mildronate at recovery treatment of patients with displazia connecting fabric
G.I. Nechayeva Nechayeva, O.V. Drokina Drokina, G.S. Dubilya Dubilya, I.V. Druk Druk, Omsk State Medical Academy, 644043 ul. Lenina, 12, Omsk, Russia
Kardiologiya, 2014 - [Protein-energy malnutrition in clinical practice].
Ksperimental Nai Combining Double Inverted Breve A I Klinicheskai Combining Double Inverted Breve A Gastronterologii Combining Double Inverted Breve A Experimental Clinical Gastroenterology, 2013 - Clinical effectiveness of mildronate in patients with connective tissue dysplasia: Experience of the specialized clinical centre, Omsk city
Russian Journal of Cardiology, 2011
